CVS Health Common Stock increased by 0.4% to $50.40B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $49.66B to $50.40B. Over 5 years (FY 2020 to FY 2025), Common Stock shows relatively stable performance with a 1.6% CAGR.
An increase suggests equity financing activities, while a decrease may result from share cancellations or accounting reclassifications.
The aggregate par value of common shares issued plus the excess amount paid by investors over the par value. This reflec...
Standard line item across all public companies representing core equity funding.
equity_common_stocks_including_additional_paid_in_capital| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.00B | $47.13B | $47.38B | $47.68B | $47.87B | $48.05B | $48.19B | $48.31B | $48.65B | $48.83B | $48.99B | $49.21B | $49.37B | $49.51B | $49.66B | $49.84B | $50.02B | $50.18B | $50.40B |
| QoQ Change | — | +0.3% | +0.5% | +0.6% | +0.4% | +0.4% | +0.3% | +0.2% | +0.7% | +0.4% | +0.3% | +0.4% | +0.3% | +0.3% | +0.3% | +0.4% | +0.4% | +0.3% | +0.4% |
| YoY Change | — | — | — | — | +1.9% | +1.9% | +1.7% | +1.3% | +1.6% | +1.6% | +1.7% | +1.9% | +1.5% | +1.4% | +1.4% | +1.3% | +1.3% | +1.4% | +1.5% |